INTERNATIONAL PATENT: ALKEUS PHARMACEUTICALS, INC. FILES APPLICATION FOR "10MG TO 35MG OF GILDEURETINOL FOR USE IN THE TREATMENT OF STARGARDT DISEASE"

GENEVA, July 14 -- ALKEUS PHARMACEUTICALS, INC. (44 Brattle St, Fl 2Cambridge, Massachusetts 02138) filed a patent application (PCT/US2024/062409) for "10MG TO 35MG OF GILDEURETINOL FOR USE IN THE TREATMENT OF STARGARDT DISEASE" on Dec 31, 2024. With publication no. WO/2025/147467, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAAD, Leonide C. (44 Brattle St, Fl 2Cambridge, Massachusetts 02138)

Abstract: Disclosed is a method of treating a patient with Stargardt Disease. Also disclosed is a method of delaying the pro...